Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in antiplatelet therapy.

Hani Jneid1, Deepak L Bhatt

  • 1Division of Cardiology, University of Louisville, KY, USA.

Expert Opinion on Emerging Drugs
|December 10, 2003
PubMed
Summary

Platelets are crucial in cardiovascular diseases (CVDs) and vascular inflammation. Research focuses on developing safer antiplatelet therapies and optimizing current treatments for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.

Circulation. Heart failure·2014
Same author

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

International journal of cardiology·2014
Same author

Saxagliptin, alogliptin, and cardiovascular outcomes.

The New England journal of medicine·2014
Same author

Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD.

Clinical cardiology·2014
Same author

Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.

European journal of preventive cardiology·2014
Same author

Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk.

Journal of hypertension·2013

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) are a major cause of death globally, primarily driven by atherosclerosis.
  • Atherosclerosis affects multiple arterial systems, leading to conditions like coronary artery disease (CAD), stroke, and peripheral arterial disease (PAD).
  • Platelets, beyond their role in hemostasis, actively contribute to vascular inflammation and the progression of CVDs.

Purpose of the Study:

  • To review the pivotal role of platelets in cardiovascular diseases.
  • To discuss the current status and future directions of antiplatelet therapy.
  • To explore novel therapeutic strategies and personalized approaches in antiplatelet treatment.

Main Methods:

  • Review of existing literature on platelet function in CVDs.
  • Analysis of clinical trial data on antiplatelet agents.
  • Exploration of emerging research on novel antiplatelet targets and pharmacogenomics.

Main Results:

  • Antiplatelet agents are foundational in CVD management, with proven efficacy.
  • Platelet activation pathways offer multiple targets for new therapeutic interventions.
  • Personalized medicine approaches, including pharmacogenomics, show promise for optimizing antiplatelet therapy.

Conclusions:

  • Platelets are central to CVD pathogenesis and a key target for treatment.
  • Ongoing research aims to improve the efficacy and safety of antiplatelet strategies.
  • Optimizing existing therapies and developing novel agents are critical for reducing CVD morbidity and mortality.

Related Experiment Videos